Log In
Print
BCIQ
Print
Print this Print this
 

DPP Syphilis Screen & Confirm

  Manage Alerts
Collapse Summary General Information
Company Chembio Diagnostics Inc.
DescriptionPoint-of-care assay using Dual Path Platform (DPP) technology to detect non-treponemal and treponemal antibodies to syphilis in blood
Molecular Target
Mechanism of ActionDiagnostic; Antibody
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect syphilis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today